Bio-Technology General Corp. Announces July 24 Webcast Discussion of Earnings and the Company's Business.Business Editors ISELIN, N.J.--(BUSINESS WIRE)--July 20, 2001 Bio-Technology General Corp. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :BTGC BTGC Bio-Technology General (stock symbol) BTGC Bukit Tinggi Golf Club (Malaysia) ) will announce its second quarter 2001 earnings results on Tuesday, July 24, 2001, before the market open. The announcement will be followed by a live webcast discussion by BTG BTG BIT (Built-In Test) Target Generator BTG Bridging the Gap BTG British Technology Group BtG Betreuungsgesetz (Germany) BTG Biomass Technology Group BV BTG Begbies Traynor Group management of the earnings and the Company's business at 10:00 a.m. (EST EST electroshock therapy. EST abbr. electroshock therapy ). The live webcast can be accessed by going to BTG's website at www.btgc.com and will be archived through July 31, 2001. An audio replay will be available after 12:30 EST on July 24, 2001 through July 31, 2001 and can be accessed by dialing 888-203-1112 (in the U.S.) or 719-457-0820 (from overseas); passcode number is 431607. Bio-Technology General Corp., a leading biopharmaceutical company, develops, manufactures and markets genetically engineered genetically engineered adjective Recombinant, see there and other products for human health care. Statements in this news release concerning the Company's business outlook or future economic performance, anticipated profitability, revenues, expenses or other financial items; and statements concerning assumptions made or expectations as to any future events, conditions, performance or other matters, are "forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. " as that term is defined under the Federal Securities Laws. Forward-looking statements are subject to risks, uncertainties and other factors which could cause actual results to differ materially from those stated in such statements. Such risks, uncertainties and factors include, but are not limited to, changes and delays in product development plans and schedules, customer acceptance of new products, changes in pricing or other actions by competitors, patents owned by the Company and its competitors, and general economic conditions, as well as other risks detailed in the Company's filings with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion